IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4188
Positioning
Market Dominance
Services
Computer Software
$479M
Jia Y. Lin
Cango Inc. operates an automotive transaction service platform that connects dealers, original equipment manufacturer, financial institutions, car buyers, and other industry participants. The company offers automobile trading solutions, including car sourcing, logistics, and warehousing support for dealers. It also facilitates automotive financing services that include facilitating financing transactions from financial institutions to car buyers.
Headcount
2.4K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = CANG ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$CANG Cango Inc. | 34 | 46 | 73 | 4 | 10.1x | 1.1x | 29.3% | 20.1% | 21.8% | 22.2% | 37.3% | -54.0% | 0.0% | 4.0x | $479M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
Cango Inc. (CANG) receives a "Avoid" rating with a composite score of 34.3/100. It ranks #4188 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
HQ Base
Pending Verification
Lagging peers — losers tend to keep underperforming
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for CANG.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 46 | 48 | -2NEUTRAL |
| MOMENTUM | 4 | 2 | +2NEUTRAL |
| VALUATION | 73 | 83 | -10DRAG |
| INVESTMENT | 29 | 28 | +1NEUTRAL |
| STABILITY | 28 | 19 | +9ALPHA |
| SHORT INT | 23 | 8 | +15ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 29.3% (sector 5.7%)
GM 22% vs sector 65%, OM 22% vs sector 5%
Capital turnover N/A, R&D intensity 0.7%
Rev growth -54%, 7yr history
Interest coverage 271.4x, Net debt/EBITDA -4.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Cango Inc. (CANG) as Avoid with a composite score of 34.3/100 at a current price of $0.86. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
Cango Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 34.3/100 places it at rank #4188 in our full universe.
Narrow
Medium
Exemplary
Undervalued
Returns on equity of 29.3% exceed cost of capital.
Value factor score of 73 suggests attractive pricing.
Stable competitive position in a defensive sector.
Weak momentum suggests persistent institutional selling pressure.
Vulnerability to macroeconomic shocks and interest rate volatility.
Cango Inc. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags Cango Inc. with an Avoid rating, assigning a composite score of 34.3/100 and 1 out of 5 stars. Ranked #4188 of 7,333 stocks, CANG falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
With a quality score of 46/100, CANG shows adequate but unremarkable business quality. The company reports a return on equity of 29.3% (sector avg: 5.7%), gross margins of 21.8% (sector avg: 64.6%), net margins of 37.3% (sector avg: 2.8%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
CANG carries a solid value score of 73/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 10.13x, an EV/EBITDA of 1.07x, a P/B ratio of 0.57x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
Cango Inc.'s investment score of 29/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -54.0% vs. a sector average of 8.6% and a return on assets of 20.1% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Cango Inc. is experiencing notably weak momentum with a score of just 4/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -54.0% year-over-year, while a beta of 1.00 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
CANG's stability score of 28/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 1.00 and a debt-to-equity ratio of 4.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
Cango Inc.'s short interest score of 23/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 4.00x), small-cap liquidity risk. At $479M (small-cap), CANG carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Cango Inc. is a small-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #4188 of 7,333 overall (43rd percentile). Key comparisons include ROE of 29.3% exceeding the 5.7% sector median and operating margins of 22.2% above the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While CANG currently exhibits a AVOID profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (4) would have the largest impact on the composite score.
EV/EBITDA 91% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 411% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 66% BELOW SECTOR MEDIAN

Cango Inc. agreed to sell its China-based business for $352 million, a move that could pave the way for a Singapore-linked entity to take control of the company as it transitions from a car trader to a bitcoin miner.

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115. Myomo, Inc. (NYSE: MYO) shares rose 40.4% to $0.8551. Myomo recently posted upbeat quarterly results. Edible Garden AG Incorporated (NASDAQ: EDBL) gained 37.7% to $0.42. XPeng Inc. (NYSE: XPEV) shares surged 36.2% to $10.00 after the company reported Q3 earnings and delivery results and issued Q4 sales and delivery guidance. Qutoutiao Inc. (NASDAQ: QTT) gained 31.8% to $0.4787. Vapotherm, Inc. (NYSE: VAPO) rose 28.6% to $0.8490 after declining around 10% on Tuesday. Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) shares jumped 27.7% to $100.59 after the company confirmed preliminary discussions regarding a potential offer. The company is in discussions with Amgen, Janssen and Sanofi. Otonomy, Inc. (NASDAQ: OTIC) rose 27.3% to $0.2914 after jumping around 114% on Tuesday. The company recently posted a quarterly loss of $0.18 per share. Check-Cap Ltd. (NASDAQ: CHEK) surged 26.7% to $3.73. Check-Cap reported a Q3 net loss of $4.7 million. Satixfy Communications Ltd. (NYSE: SATX) gained 23.5% to $19.00. Uxin Limited (NASDAQ: UXIN) gained 21% to $2.6884. Agora, Inc. (NASDAQ: API) climbed 20.8% to $3.2016. Immunome, Inc. (NASDAQ: IMNM) climbed 19.8% to $4.4683. Immunome recently posted a Q3 loss of $0.75 per share. NIO Inc. (NYSE: NIO) gained 19.8% to $12.58 in sympathy with Xpeng after the company reported Q3 earnings and delivery results and issued Q4 guidance. Kingsoft Cloud Holdings Limited (NASDAQ: KC) surged 17.7% to $2.99. Atour Lifestyle Holdings Limited (NASDAQ: ATAT) gained 17.4% to $14.97. Li Auto Inc. (NASDAQ: LI) jumped 16.6% to $21.61 in sympathy with XPeng, which gained after the company reported Q3 earnings and delivery results and issued Q4 sales and delivery guidance. Dada Nexus Limited (NASDAQ: DADA) climbed 16.5% to $6.59. GDS Holdings Limited (NASDAQ: GDS) gained 16.3% to $15.69. Eargo, Inc. (NASDAQ: EAR) gained 16% to $0.6201 after the company was granted US Patent #11516601: Hearing assistance ...

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Hims & Hers Health, Inc. (NYSE: HIMS) shares jumped 22.1% to $5.64 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Lordstown Motors Corp. (NASDAQ: RIDE) gained 13.5% to $2.10 in pre-market trading after the company announced Foxconn will invest up to $170 million in the company. 2U, Inc. (NASDAQ: TWOU) surged 11.6% to $7.10 in pre-market trading after reporting strong Q3 sales. Piper ...

Gainers Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 25.5% to $2.71 in pre-market trading after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement. Hims & Hers Health, Inc. (NYSE: HIMS) rose 22.1% to $5.64 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Tenaya Therapeutics, Inc. (NASDAQ: TNYA) shares rose 17.7% to $2.26 in pre-market trading. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21. uCloudlink Group Inc. (NASDAQ: UCL) rose 17.2% to $1.08 in pre-market trading after gaining over 4% on Monday. ContraFect Corporation (NASDAQ: CFRX) rose 15.2% to $0.1797 in pre-market trading after dropping over 5% on Monday. Lordstown Motors Corp. (NASDAQ: RIDE) rose 13.5% to $2.10 in pre-market trading after the company announced Foxconn will invest up to $170 million in the company. 2U, Inc. (NASDAQ: TWOU) rose 11.6% to $7.10 in pre-market trading after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target ...

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after climbing over 32% on Tuesday. FLJ Group Limited (NASDAQ: FLJ) jumped 86.3% to close at $2.85 on Wednesday. 9F Inc. (NASDAQ: JFU) gained 83.4% to close at $0.3485. FOXO Technologies Inc. (NASDAQ: FOXO) jumped 59.3% to close at $1.43 after the company announced its insurance distribution subsidiary, FOXO LIFE, recruited its first distribution partner, BGA Insurance, to begin product rollout in California. Happiness Development Group Limited (NASDAQ: HAPP) climbed 59.1% to close at $3.85. Happiness Development Group shareholders approved a 1 for 20 reverse split of ordinary shares. Hempacco Co., Inc. (NASDAQ: HPCO) shares gained 43.4% to close at $3.14 after the company reported a 486% year-on-year jump in first-half FY22 revenue to about $2.8 million. mCloud Technologies Corp. (NASDAQ: MCLD) jumped 39.4% to close at $2.23. Code Chain New Continent Limited (NYSE: CCNC) shares climbed 38.8% to close at $0.2290 on Wednesday after declining around 14% on Tuesday. Vigil Neuroscience, Inc. (NASDAQ: VIGL) gained 37% to close at $13.92. Applied DNA Sciences, Inc(NASDAQ: APDN) rose 36.5% to close at $2.73. Applied DNA Sciences recently received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. Aspen Group, Inc. (NASDAQ: ASPU) rose 35.3% to settle at $0.4424 after the company cancelled its equity distribution agreement. Pineapple Energy Inc.. (NASDAQ: PEGY) jumped 34% to close at $6.70. The stock has been a momentum name for a few weeks now. Meta Materials Inc. (NASDAQ: MMAT) gained 33% to close at $1.05. Oriental Culture Holding LTD (NASDAQ: OCG) rose 31.6% to close at $0.89. Compugen Ltd. (NASDAQ: CGEN) gained 29.2% to close at $0.8521. Gatos Silver, Inc. (NYSE: GATO) gained 29.1% to close at $3.33. Gatos Silver reported a 59% year-over-year surge in Q3 silver production. Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) gained 28.8% to close at $0.79. Celularity Inc. (NASDAQ: CELU) gained 20.9% to close at $2.26. LumiraDx Limited (NASDAQ: LMDX) jumped 20.9% to settle at $1.04. Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) surged 18% to close at $0.1728 after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic alternatives. ObsEva SA (NASDAQ: OBSV) rose 16.9% to close at $0.1851 after dropping 3% on Tuesday. El ...
Above 50MA
37.18%
Net New Highs
+51081